Cargando…
Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance
In recent years, therapy with immune modulating antibodies, termed immune checkpoint blockade (ICB), has revolutionized the treatment of advanced metastatic melanoma, yielding long-lasting clinical responses in a subgroup of patients. But despite this remarkable progress, resistance to therapy repre...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Shared Science Publishers OG
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841847/ https://www.ncbi.nlm.nih.gov/pubmed/33554047 http://dx.doi.org/10.15698/cst2021.02.242 |